Thioamides: Synthesis, stability, and immunological activities of thioanalogues of imreg. Preparation of new thioacylating agents using fluorobenzimidazolone derivatives

Journal of Medicinal Chemistry

Volumn 42, Issue 11, 1999, Pages 2046-2052

  Zacharie, Boulos ^a   Lagraoui, Mouna ^a   Dimarco, Marika ^a   Penney, Christopher L ^a   Gagnon, Lyne ^a  

^a Shire Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC AGENT; IMREG 1; LEVO THIOTYROSINYLGLYCYLGLYCINE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOLOGY; CELL PROLIFERATION; CYTOTOXICITY; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IMMUNOSTIMULATION; NONHUMAN; PROTEIN MODIFICATION; RAT; T LYMPHOCYTE; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL DIVISION; CELLS, CULTURED; DRUG STABILITY; ENDOPEPTIDASES; FEMALE; IMMUNOPHENOTYPING; KIDNEY; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICROVILLI; OLIGOPEPTIDES; RATS; SPLEEN;

EID: 0033519736     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9900467     Document Type: Article

References (47)

1. (a) Gottlieb, A. A. U.S. patents 4 699 898, 1987; 4 751 216,1988; and 5 100 663, 1992.
2. (a) Gottlieb, A. A. U.S. patents 4 699 898, 1987; 4 751 216,1988; and 5 100 663, 1992.
3. (a) Gottlieb, A. A. U.S. patents 4 699 898, 1987; 4 751 216,1988; and 5 100 663, 1992.
4. (b) Gottlieb, A. A. Clinical and immunologic observations in patients with aids-related complex treated with Imreg-1. Int. J. Immunopharmacol. 1991, 13 (1), 29-32.
5. (a) Sizemore, R. C.; Dienglewicz, R. L.; Pecunia, E.; Gottlieb, A. A. Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by leu-enkephalin and related peptides. Clin. Immunol. Immunopathol. 1991, 60 (2), 310-318.
6. (b) Gottlieb, A. A.; Gottlieb, M. S.; Sinha, S.; Sizemore, R.; Kern, C. H. Clinical and immunological effects of IMREG-1 and IMREG-2, two immunoregulators derived from leukocytes. Int. J. Immunother. 1988, 4 (4), 199-201.
7. (a) Fiala, M.; Cone, L. A.; Sayre, J. W. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Int. J. Immunopharmacol. 1991, 13 (7), 999.
8. (b) Gottlieb, M. S.; Zackin, R. A.; Fiala, M.; Henry, D. H.; Marcel, A. J.; Combs, K. L.; Vieira, J.; Liebman, H. A.; Cone, L. A.; Hillman, K. S. Response to treatment with the deukocyte-derived immunomodulator Imreg-1 in immunocompromised patients with aids-related complex. A multicenter, double-blind, placebo-controlled trial. Ann. Intern. Med. 1991, 115 (2), 84-91.
9. DeGraw, J. I.; Almquist, R. G.; Hiebert, C. K.; Colwell, W. T.; Crase, J.; Hayano, T.; Judd, A. K.; Dousman, L.; Smith, R. L.; Waud, W. R.; Uchida, I. Stabilized analogues of thymopentin 1.4,5-ketomethylene pseudopeptides. J. Med. Chem. 1997, 40, 2386-2397.
10. Review: Spatola, A. F. In Chemistry and Biochemistry of Amino Acids, Peptides and Proteins; Weinstein, B., Ed.; Marcel Dekker: New York, 1983; Vol. 7, Chapter 5, pp 267-357.
11. (a) Mock, W. L.; Chen, J.-T.; Tsang, J. W. Hydrolysis of a thiopeptide by cadmium carboxypeptidase A. Biochem. Biophys. Res. Commun. 1981, 102, 389-396.
12. (b) Bartlett, P. A.; Spear, K. L.; Jacobson, N. E. A thioamide substrate of carboxypeptidase A. Biochemistry 1982, 21, (7), 1608-1611.
13. (c) Campbell, P.; Nashed, N. T. Carboxypeptidase A catalyzed hydrolysis of thiopeptide and thioester analogues of specific substrates. An effect on kcat for peptide, but not ester, substrates. J. Am. Chem. Soc. 1982, 104, (19), 5221-5226.
14. (d) Bond, M. D.; Holmquist, B.; Vallee, B. L. Thioamide substrate probes of metal-substrate interactions in carboxypeptidase A catalysis. J. Inorg. Biochem. 1988, 28 (2-3), 97-105.
15. (e) Beattie, R. E.; Elmore, D. T.; Williams, C. H.; Guthrie, D. J. S. The behaviour of leucine aminopeptidase towards thionopeptides. Biochem. J, 1987, 245 (1), 285-288.
16. Kessler, H.; Matter, H.; Geyer, A.; Diehl, H.; Kock, M.; Kurz, G.; Opperdoes, F. R.; Callens, M.; Weirenga, R. K. Selective inhibition of trypanosomal triose phosphate isomerase with a thiopeptide. Angew. Chem. Int. Ed. Engl. 1992, 31 (3), 328-230.
17. (a) Clausen, K.; Spatula, A. F.; Lemieux, C.; Schiller, P. W.; Lawesson, S.-O. Evidence of a peptide backbone contribution toward selective receptor recognition for leucine enkephalin thioamide analogues. Biophys. Res. Comm. 1984, 120 (1), 305-310.
18. (b) Lajoie, G.; Lepine, F.; Lemaire, S.; Jolicoeur, F.; Aube, C.; Turcotte, A.; Belleau, B. Synthesis and biological activity of monothionated analogues of leucine-enkephalin. Int. J. Pept. Protein Res. 1984, 24 (4), 316-327.
19. (c) Reid, W.; Von Der Emden, W. Aminosäure-thionester und Endothiopeptide, II. (Amino acidthionoester and endothiopeptide, II.) Chem. Ber. 1956, 89, 128-140.
20. (d) Brown, D. W.; Campbell, M. M.; Chambers, M. S.; Walker, C. V. Mono-and dithionopeptide synthesis. Tetrahedron Lett. 1987, 28 (19), 2171-2174.
21. (e) Kruszynski, M.; Kupryszewki, G.; Ragnarsson, U.; Alexandrova, M.; Strbak, V.; Tonon, M. C.; Vaudry, H. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity. Experientia 1985, 41 (12), 1576-1577.
22. Schutkowski, M.; Wollner, S.; Fisher, G. Inhibition of peptidylprolyl cis/trans isomerase activity by substrate analogue structures: thioxo tetrapeptide-4-nitroanilides. Biochemistry 1995, 34, (40), 13016-13026.
23. Zacharie, B.; Martel, R.; Sauvé, G.; Belleau, B. Chemoselective thioacylation of amino acids. Preparation of the four monothiothymopentin analogues and their biological activity. Biorg. Med. Chem. Lett. 1993, 3, 619-624.
24. Zacharie, B.; Sauvé, G.; Penney, C. Thioacylating Agents. Use of Thiobenzimidazolone derivatives for the preparation of thiotuftsin analogues. Tetrahedron 1993, 49, 10489-10500.
25. (a) Seebach, D.; Lubosch, W.; Enders, D. Nucleophilic thioacylation with thiocarbamoyllithium derivatives of secondary amines. Chem. Ber. 1976, 109 (4), 1309-1323.
26. (b) Metsger, J. V. In Comprehensive Heterocyclic Chemistry; Katrezky, A. R., Rees, C. W., Eds.; Pergmon Press: Oxford, 1984; Vol. 6, p 235.
27. Babudri, F.; Fiandanese, V.; Marchese, G.; Punzi, A. A simple synthesis of thioamides. Synlett 1994, 719-720.
28. (a) Pedersen, B. S.; Scheibye, S.; Nilson, N. H.; Lawesson, S. O. Studies on organophosphorus compounds XX. Syntheses of thioketones. Bull. Soc. Chim. Belg. 1978, 87, 223-228.
29. (b) Cava, M. P.; Levinson, M. I. Thionation reactions of Lawesson's reagents. Tetrahedron 1985, 41, 5061-5087 and references therein.
30. Kessler, H.; Geyer, A.; Matter, H.; Köck, M. Unusual thionation of a cyclic hexapeptide. Conformational changes and dynamics. Int. J. Pept. Protein Res. 1992, 40 (1), 25-40.
31. (a) Hartke, K. New aspects of dithio and thiono esters. Phosphorus, Sulfur Silicon 1991, 58, 223-253.
32. (b) Brutsche, A.; Hartke, K. Synthese von N-geschützten, optisch aktiven α-aminothionsäureestern. (Synthesis of N-protected optically active α-aminothiono acid ester.) Liebigs Ann. Chem. 1992, 921-925.
33. (c) Kato, S.; Sugino, K.; Matzuzawa, Y.; Katada, T.; Noda, I.; Mizuta, M.; Goto, M.; Ishida, M. The preparation and some reactions of unsymmetrical acyl thioacyl sulfides. Liebigs Ann. Chem. 1981, 1789.
34. (a) Guthrie, D. J. S.; Williams, C. H.; Elmore, D. T. Configuration of thionopeptide bond in solution. Int. J. Pept. Protein Res. 1986, 28, 208-211.
35. (b) Ried, W.; Schmidt, E. N-acylierte α-aminoimidsäureester, iminodipeptide und Endothiodipeptide. (N-Acylated α-aminoimido acid ester, iminodipeptide, and endothiodipeptide.) Liebigs Ann. Chem. 1968, 695, 217.
36. Thorsen, M.; Yde, B.; Pedersen, U.; Clausen, K.; Lawesson, S.-O. Studies on amino acids and peptides-V. Synthesis of endothionated melanostatin analogues. Tetrahedron 1983, 39, 3429-3435 and references therein.
37. Jurayj, J.; Cushman, M. Approaches to the synthesis of endothiopeptides: Synthesis of a thioamide-containing C-terminal bombesin nonpeptide. Tetrahedron 1992, 48 (40), 8601-8614.
38. Hoeg-Jensen, T.; Holm, A.; Sorensen, H. Peptide thioacylation with high stereochemical preservation. Synthesis 1996, 383-387 and references therein.
39. Brain, C. T.; Hallett, A.; Ko, S. Y. Thioamide synthesis: Thioacyl-N-phthalimides as thioacylating agents. J. Org. Chem. 1997, 62, 3808-3809.
40. Shalaby, M. A; Grote, C. W.; Rapoport, H. Thiopeptide synthesis. α-Amino thionoacid derivatives of nitrobenzotriazole as thioacylating agents. J. Org. Chem. 1996, 61, 9045-9048.
41. Zacharie, B. In New Strategies for the Design and Synthesis of Small Immunostimulant Molecules, Recent Res. Devel. in Organic Chem.; Pandalai, S. G., Ed.; Transworld Research Network 1997, 1, 313-335.
42. Zacharie, B. Unpublished results.
43. As demonstrated by the metabolic degradation of eukephalins: Neville, M.; Alice, G.; Amos, N. On the degradation of eukephalins and endorphins by rat and mouse brain extracts. Biochem. Biophys. Res. Comm. 1977, 74 (4), 1552-1559.
44. Sizemore, R. C.; Kern, C. H., Gottlieb, M. S., Gottlieb A. A. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by Imreg-1: a measure of the immunopotentiation of cell-mediated immunity. Clin. Immunol. Immunopathol. 1995, 76 (3 Pt 1), 308-313.
45. Kowalski, J. Immunologic action of (MetS) enkephalin fragments. Eur. J. Pharmacol. 1998, 347, 95-99.
46. Maeda, T.; Balakrishnan, K.; Mehdi, S. Q. A simple and rapid method for the preparation of plasma membranes. Biochim. Biophys. Acta 1983, 731, 115-120.
47. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 7 (72), 248-254.